Status:
UNKNOWN
Efficacy of Hydrogen Breath Test in the Patients With Irritable Bowel Syndrome
Lead Sponsor:
Yonsei University
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Irritable bowel syndrome is characterized by abdominal discomfort and bowel habit change. It is increasing worldwide. But the pathophysiology of the irritable bowel syndrome is not proven. So, the tre...
Eligibility Criteria
Inclusion
- over 19 years old, male and female
- normal people (control group, who has no abdominal symptoms - diarrhea, constipation etc.)
- irritable bowel syndrome patients (irritable bowel syndrome means that within the last 3 months abdominal discomfort more than three days for a month and satisfies over the below two items) 1) symptom relived after defecation 2) bowel habit change, the times of defecation changed 3) the change of the morphology of the stool
Exclusion
- patients who do not agree for participation
- patients who have history for treatment of irritable bowel syndrome
- patients who is uncontrolled diabetes mellitus
- patients who have small bowel or large bowel diseases
- patients who had surgery for abdomen
- patients who are taking antibiotics, anti-depressants within 1 week
- patients who are taking proton pump inhibitors or opioids for analgesics
- patients who have history of bowel adhesion
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
147 Patients enrolled
Trial Details
Trial ID
NCT02242175
Start Date
September 1 2014
End Date
August 1 2020
Last Update
March 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sevrance hospital
Seoul, South Korea, 120-752